Australia, Nov. 11 -- Amylyx Pharmaceuticals Inc., owns the trademark (2542257) for 'AMYLYX' till March 21, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders.]
Type of Mark: Word
Date of Acceptance: Sept. 3
Registration Advertised: Nov. 10
For further details contact Vardon Legal and Fish & Richardson P.C..
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2542257.
Disclaimer: Curated by HT Syndication....